Nearly Half of Hepatitis C Patients on Medicaid Denied Coverage for Life-Saving Drugs, Penn Researchers Report
First Data to Report on Denial and Delay Rates for Hepatitis C Antiviral Agents Nearly 50 percent of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they weren’t considered “a medical necessity” or because the patients tested positive for alcohol/drugs, among … Read more